The effect of acetyl-L-carnitine and R-α-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease
- 2 April 2009
- journal article
- research article
- Published by Elsevier BV in Journal of the Neurological Sciences
- Vol. 283 (1-2), 199-206
- https://doi.org/10.1016/j.jns.2009.03.002
Abstract
No abstract availableThis publication has 65 references indexed in Scilit:
- Mitochondrial Abnormalities in Alzheimer’s DiseasePublished by Elsevier BV ,2012
- Neuronal mitochondrial amelioration by feeding acetyl‐L‐carnitine and lipoic acid to aged ratsJournal of Cellular and Molecular Medicine, 2009
- Localized Cerebral Blood Flow Reductions in Patients With Heart Failure: A Study Using 99mTc-HMPAO SPECTJournal of Neuroimaging, 2005
- A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse ModelJournal of Neuroscience, 2005
- Vascular Basis of Alzheimer's PathogenesisAnnals of the New York Academy of Sciences, 2002
- Alzheimer Disease as a Vascular DisorderStroke, 2002
- Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PETBrain, 1999
- Oxidative Stress Hypothesis in Alzheimer's DiseaseFree Radical Biology & Medicine, 1997
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 1993